✦ LIBER ✦

Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer

✍ Scribed by Tomioka, Atsushi; Tanaka, Nobumichi; Yoshikawa, Motokiyo; Miyake, Makito; Anai, Satoshi; Chihara, Yoshitomo; Okajima, Eijiro; Hirayama, Akihide; Hirao, Yoshihiko; Fujimoto, Kiyohide

Book ID: 125399792
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 162 KB
Volume: 14
Category: Article
ISSN: 1471-2490
DOI: 10.1186/1471-2490-14-33

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

143 NADIR PSA AND TIME TO PSA PROGRESSIO

143 NADIR PSA AND TIME TO PSA PROGRESSION PREDICT OVERALL SURVIVAL IN PATIENTS WITH METASTATIC PROSTATE CANCER

✍ A. Tomioka; N. Tanaka; M. Miyake; T. Inoue; S. Anai; T. Ikeda; K. Fujimoto; Y. H 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 98 KB

MP-16.03 Nadir Prostate Specific Antigen

MP-16.03 Nadir Prostate Specific Antigen (PSA) Level and Time to PSA Nadir Following Primary Androgen Deprivation Therapy Are the Early Survival Predictors for Prostate Cancer Patients with Bone Metastasis

✍ T. Sasaki; T. Onishi; A. Hoshina 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Nadir prostate-specific antigen (PSA) le

Nadir prostate-specific antigen (PSA) level and time to PSA nadir following primary androgen deprivation therapy as independent prognostic factors in a Japanese large-scale prospective cohort study (J-CaP)

✍ Kitagawa, Yasuhide; Ueno, Satoru; Izumi, Kouji; Mizokami, Atsushi; Hinotsu, Shir 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 269 KB

Time to prostate specific antigen (PSA)

Time to prostate specific antigen (PSA) nadir may predict rapid relapse in men with metastatic castration-resistant prostate cancer (CRPC) receiving docetaxel chemotherapy

✍ Thomas, Betsan M.; Smith, Christian; Evans, Jessica; Button, Michael R.; Kumar, 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 193 KB

What does postradiotherapy PSA nadir tel

What does postradiotherapy PSA nadir tell us about freedom from PSA failure and progression-free survival in patients with low and intermediate-risk localized prostate cancer?

✍ K.D DeWitt; H.M Sandler; V Weinberg; P.W McLaughlin; M Roach III 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Correlation Between PSA Bounce, Time to

Correlation Between PSA Bounce, Time to Nadir, and Biochemical Failure in Patients With Prostate Cancer Treated With a Combination of HDR-Brachytherapy and Hypofractionated External Beam Radiation Therapy

✍ Patel, N.; Cury, F.; Souhami, L.; Aprikian, A.; Faria, S.; David, M.; Duclos, M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 51 KB